Hubert L. Allen, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 11,733 shares at $45.01 ($533K) on 2017-02-28, disclosed to the SEC on 2017-03-02.
Scheduled sale ($533k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 857 | $39K | 7.2% |
| 2 | $45.46 | 10,876 | $494K | 92.8% |
| Total | $45.43 avg | 11,733 | $533K | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $202K | — | Filing → |
| ABT | SELL | 2023-03-02 | $215K | — | Filing → |
| ABT | SELL | 2022-03-02 | $343K | — | Filing → |